Kliničke studije za Астма u državi Kentaki
6 studija za Астма traži učesnike na lokacijama u državi Kentaki.
Zvanični tekst studije (na engleskom)
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Louisville
- Research Site, Louisville
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 10. 11. 2026. · NCT06307665A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Allergy & Asthma Specialists, P.S.C., Owensboro
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07219173A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Owensboro
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07645248Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Louisville
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT06932263A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Owensboro
Тражи се учесникФаза 2
Узраст од 4 до 11 · Оба пола · Ажурирано 13. 10. 2026. · NCT07525375ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Owensboro
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 24. 9. 2026. · NCT07301255Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.